Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Jennifer Linehan is a pioneering urologic surgeon and researcher whose work has fundamentally advanced the field of robotic surgery for genitourinary cancers. Her primary research focuses on refining minimally invasive techniques, particularly robot-assisted radical cystectomy (RARC) for bladder cancer, where she has established new standards for patient safety. In her landmark 2012 study, cited over 150 times, she introduced a standardized system for analyzing complications after RARC, providing the first comprehensive framework for comparing surgical outcomes. She further expanded this work in 2013, demonstrating how urinary diversion type directly influences complication profiles—a critical insight that has shaped preoperative counseling and surgical planning. With over 100 citations, these studies remain foundational references in urologic oncology. Dr. Linehan has also contributed to prostate cancer risk stratification, developing biomarker models using expressed prostatic secretions to improve active surveillance candidacy. Most recently, she is at the forefront of single-port robotic surgery, leading multi-institutional trials through the Single Port Advanced Research Consortium (SPARC). Her work on single-port partial nephrectomy and the broader landscape of this emerging technology positions her as a key architect of the next generation of scarless, less invasive urologic surgery.